Currently, there are many treatments that slow down the progression of multiple myeloma, reduce tumors, and relieve pain and other symptoms. Clinical trials are also available at every stage of treatment.

Multiple myeloma treatments are tailored to patients’ age, general health, lifestyle, goals for treatment, response to any previous treatments, the disease’s stage, and whether the disease is active or inactive.

Smoldering multiple myeloma, also called inactive or asymptomatic multiple myeloma, is a stable form of myeloma where the affected …

Any person’s individual multiple myeloma prognosis depends on several health factors. People who have kidney damage or who are older are more likely to have poorer prognoses. Additionally, doctors perform many tests to get an overall picture of how a person’s body is responding to myeloma.

Samples of a person’s bone marrow can be tested for different factors that affect prognoses. A lab test called the myeloma cell staging index or plasma cell labeling index can show the percentage of …